Dr. Garner Discusses the myRisk Hereditary Cancer Test
Elizabeth Garner, MD, MPH, vice president, Clinical Affairs, Preventive Care, Myriad Genetics, discusses the myRisk Hereditary Cancer Test.
Elizabeth Garner, MD, MPH, vice president, Clinical Affairs, Preventive Care, Myriad Genetics, discusses the myRisk Hereditary Cancer Test.
Garner explains that myRisk is a genetic test that looks for mutations in 25 genes that are known to be associated with significantly elevated risk for cancer. There are eight major cancers that the test can detect, such as breast cancer, ovarian cancer, melanoma, and endometrial cancer.
The test allows physicians to increase the rate of detection for individuals that have mutations or who have hereditary cancer syndromes, Garner says. The increased ability to detect these patients allows these patients to better manage their health, in order to reduce their risk of developing cancer.
<<<
